Bradley N Gaynes

Author PubWeight™ 119.24‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol 2005 8.67
2 Screening for depression in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002 7.78
3 The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry 2005 4.45
4 Screening for depression in adult patients in primary care settings: a systematic evidence review. Ann Intern Med 2009 4.17
5 Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians. Ann Intern Med 2008 2.65
6 Screening for and treatment of suicide risk relevant to primary care: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2013 2.36
7 Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis. Ann Intern Med 2011 2.31
8 Deployment and the use of mental health services among U.S. Army wives. N Engl J Med 2010 2.21
9 Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2007 2.02
10 Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the Southeastern United States. J Acquir Immune Defic Syndr 2006 2.01
11 Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder. Ann Intern Med 2005 1.83
12 Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report. Am J Psychiatry 2007 1.67
13 Deployment and mental health diagnoses among children of US Army personnel. Arch Pediatr Adolesc Med 2011 1.66
14 Interventions to prevent post-traumatic stress disorder: a systematic review. Am J Prev Med 2013 1.64
15 Increase in work productivity of depressed individuals with improvement in depressive symptom severity. Am J Psychiatry 2013 1.61
16 STAR*D: revising conventional wisdom. CNS Drugs 2009 1.41
17 Depression, sexually transmitted infection, and sexual risk behavior among young adults in the United States. Arch Pediatr Adolesc Med 2009 1.41
18 Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care. Neuropsychopharmacology 2007 1.39
19 Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report. Am J Psychiatry 2009 1.38
20 Joint effects of alcohol consumption and high-risk sexual behavior on HIV seroconversion among men who have sex with men. AIDS 2013 1.27
21 Comparative risk for harms of second-generation antidepressants : a systematic review and meta-analysis. Drug Saf 2008 1.20
22 Treating depression within the HIV "medical home": a guided algorithm for antidepressant management by HIV clinicians. AIDS Patient Care STDS 2012 1.18
23 Insomnia in patients with depression: a STAR*D report. CNS Spectr 2010 1.18
24 Assessing the effect of Measurement-Based Care depression treatment on HIV medication adherence and health outcomes: rationale and design of the SLAM DUNC Study. Contemp Clin Trials 2012 1.14
25 Health-related quality of life in depression: a STAR*D report. Ann Clin Psychiatry 2010 1.13
26 Concise Health Risk Tracking scale: a brief self-report and clinician rating of suicidal risk. J Clin Psychiatry 2011 1.12
27 Validation of a brief screening instrument for substance abuse and mental illness in HIV-positive patients. J Acquir Immune Defic Syndr 2005 1.09
28 Diagnostic accuracy of Spanish language depression-screening instruments. Ann Fam Med 2009 1.09
29 Falling through the cracks: the gaps between depression prevalence, diagnosis, treatment, and response in HIV care. AIDS 2012 1.09
30 Validity of an interviewer-administered patient health questionnaire-9 to screen for depression in HIV-infected patients in Cameroon. J Affect Disord 2012 1.08
31 The depression treatment cascade in primary care: a public health perspective. Curr Psychiatry Rep 2012 1.06
32 Ethnicity/race and outcome in the treatment of depression: results from STAR*D. Med Care 2007 1.06
33 Clinical features of depressed outpatients with and without co-occurring general medical conditions in STAR*D. Gen Hosp Psychiatry 2004 1.01
34 The general and comparative efficacy and safety of duloxetine in major depressive disorder: a systematic review and meta-analysis. Drug Saf 2009 1.00
35 Generalist care managers for the treatment of depressed medicaid patients in North Carolina: a pilot study. BMC Fam Pract 2007 0.99
36 Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis. Int Clin Psychopharmacol 2005 0.97
37 Physical activity and depressive symptoms among pregnant women: the PIN3 study. Arch Womens Ment Health 2010 0.95
38 Depressive symptoms among working women in rural North Carolina: a comparison of women in poultry processing and other low-wage jobs. Int J Law Psychiatry 2007 0.93
39 The adverse effects of comorbid pain on depression outcomes in primary care patients: results from the ARTIST trial. Pain Med 2010 0.92
40 Providers' attitudes towards treating depression and self-reported depression treatment practices in HIV outpatient care. AIDS Patient Care STDS 2013 0.92
41 Comparative effectiveness of second-generation antidepressants for accompanying anxiety, insomnia, and pain in depressed patients: a systematic review. Depress Anxiety 2012 0.92
42 Are depressed outpatients with and without a family history of substance use disorder different? A baseline analysis of the STAR*D cohort. J Clin Psychiatry 2007 0.91
43 Guideline-concordant antidepressant use among patients with major depressive disorder. Gen Hosp Psychiatry 2010 0.91
44 Treating the physical symptoms of depression with second-generation antidepressants: a systematic review and metaanalysis. Psychosomatics 2008 0.90
45 Efficacy and tolerability of second-generation antidepressants in social anxiety disorder. Int Clin Psychopharmacol 2008 0.90
46 Atypical antipsychotic quetiapine in the management of severe refractory functional gastrointestinal disorders. Dig Dis Sci 2009 0.89
47 Practice-based interventions addressing concomitant depression and chronic medical conditions in the primary care setting: a systematic review and meta-analysis. J Prim Care Community Health 2013 0.89
48 Follow-up visits by provider specialty for patients with major depressive disorder initiating antidepressant treatment. Psychiatr Serv 2010 0.89
49 The effect of antidepressant treatment on HIV and depression outcomes: results from a randomized trial. AIDS 2015 0.89
50 Prescription refill records as a screening tool to identify antidepressant non-adherence. Pharmacoepidemiol Drug Saf 2010 0.89
51 Clinical features of depression in outpatients with and without co-occurring general medical conditions in STAR*D: confirmatory analysis. Prim Care Companion J Clin Psychiatry 2007 0.88
52 Effects of race and ethnicity on depression treatment outcomes: the CO-MED trial. Psychiatr Serv 2011 0.88
53 Treatment use and costs among privately insured youths with diagnoses of bipolar disorder. Psychiatr Serv 2012 0.87
54 Depression affects adherence measurement but not the effectiveness of an adherence intervention in heart failure patients. J Am Pharm Assoc (2003) 2009 0.86
55 Evaluation of the Menopause-Specific Quality of Life Questionnaire: a factor-analytic approach. Menopause 2012 0.86
56 An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder. J Psychiatr Pract 2008 0.86
57 Feasibility, safety, acceptability, and preliminary efficacy of measurement-based care depression treatment for HIV patients in Bamenda, Cameroon. AIDS Behav 2014 0.86
58 Stimulant treatment and injury among children with attention deficit hyperactivity disorder: an application of the self-controlled case series study design. Inj Prev 2012 0.85
59 Predicting fatigue and depression in HIV-positive gay men. Psychosomatics 2002 0.84
60 Ranking antidepressants. Lancet 2009 0.84
61 Relationship of pharmaceutical promotion to antidepressant switching and adherence: a retrospective cohort study. Psychiatr Serv 2010 0.83
62 Relationship of clinical depression to periodontal treatment outcome. J Periodontol 2002 0.82
63 Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta-analysis. Drug Saf 2014 0.81
64 Correlates and outcomes of depressed out-patients with greater and fewer anxious symptoms: a CO-MED report. Int J Neuropsychopharmacol 2011 0.81
65 Light therapy for preventing seasonal affective disorder. Cochrane Database Syst Rev 2015 0.81
66 The association between antidepressant dosage titration and medication adherence among patients with depression. Depress Anxiety 2012 0.80
67 Use of antipsychotic medications in pediatric and young adult populations: future research needs. J Psychiatr Pract 2015 0.80
68 Controlling for drug dose in systematic review and meta-analysis: a case study of the effect of antidepressant dose. Med Decis Making 2009 0.80
69 Depression and comorbid panic in primary care patients. J Affect Disord 2009 0.80
70 Investigating differences in treatment effect estimates between propensity score matching and weighting: a demonstration using STAR*D trial data. Pharmacoepidemiol Drug Saf 2012 0.80
71 Prevalence, characteristics and correlates of a positive-dementia screen in patients on antiretroviral therapy in Bamenda, Cameroon: a cross-sectional study. BMC Neurol 2013 0.79
72 A comparison of baseline sociodemographic and clinical characteristics between major depressive disorder patients with and without diabetes: a STAR*D report. J Affect Disord 2007 0.79
73 Second-generation antidepressants for seasonal affective disorder. Cochrane Database Syst Rev 2011 0.79
74 Confounding control in a nonexperimental study of STAR*D data: logistic regression balanced covariates better than boosted CART. Ann Epidemiol 2013 0.79
75 Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial. Depress Anxiety 2012 0.79
76 Comparative efficacy and risk of harms of immediate- versus extended-release second-generation antidepressants: a systematic review with network meta-analysis. CNS Drugs 2014 0.79
77 Family history of completed suicide and characteristics of major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) study. J Affect Disord 2007 0.79
78 Can shelter-based interventions improve treatment engagement in homeless individuals with psychiatric and/or substance misuse disorders?: a randomized controlled trial. Med Care 2005 0.79
79 Prevalence estimation and validation of new instruments in psychiatric research: an application of latent class analysis and sensitivity analysis. Psychol Assess 2009 0.79
80 Concise Associated Symptoms Tracking scale: a brief self-report and clinician rating of symptoms associated with suicidality. J Clin Psychiatry 2011 0.78
81 Associations between physical activity and postpartum depressive symptoms. J Womens Health (Larchmt) 2011 0.78
82 Distressing adverse events after antidepressant switch in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial: influence of adverse events during initial treatment with citalopram on development of subsequent adverse events with an alternative antidepressant. Pharmacotherapy 2012 0.78
83 Clinical and sociodemographic characteristics associated with suicidal ideation in depressed outpatients. Can J Psychiatry 2013 0.77
84 Melatonin and agomelatine for preventing seasonal affective disorder. Cochrane Database Syst Rev 2015 0.77
85 Prevalence of bipolar disorder diagnoses and psychotropic drug therapy among privately insured children and adolescents. Pharmacotherapy 2012 0.77
86 Comparative Benefits and Harms of Antidepressant, Psychological, Complementary, and Exercise Treatments for Major Depression: An Evidence Report for a Clinical Practice Guideline From the American College of Physicians. Ann Intern Med 2015 0.77
87 Performance of a Culturally Tailored Cognitive-Behavioral Intervention Integrated in a Public Health Setting to Reduce Risk of Antepartum Depression: A Randomized Controlled Trial. J Midwifery Womens Health 2015 0.77
88 Perinatal depression in HIV-infected African women: a systematic review. J Clin Psychiatry 2015 0.76
89 Balancing Contamination and Referral Bias in a Randomized Clinical Trial: An Application of Pseudo-Cluster Randomization. Am J Epidemiol 2015 0.76
90 Physical activity during pregnancy and postpartum depressive symptoms. Midwifery 2012 0.76
91 Improving Depression Among HIV-Infected Adults: Transporting the Effect of a Depression Treatment Intervention to Routine Care. J Acquir Immune Defic Syndr 2016 0.75
92 Risk of adverse events in treatment-resistant depression: propensity-score-matched comparison of antidepressant augment and switch strategies. Gen Hosp Psychiatry 2011 0.75
93 Relationship between ever reporting depressive symptoms and all-cause mortality in a cohort of HIV-infected adults in routine care. AIDS 2017 0.75
94 Screening for and treatment of suicide risk relevant to primary care--in response. Ann Intern Med 2013 0.75
95 Differential service utilization associated with trauma-informed integrated treatment for women with co-occurring disorders. Adm Policy Ment Health 2012 0.75
96 Psychological therapies for preventing seasonal affective disorder. Cochrane Database Syst Rev 2015 0.75
97 Second-generation antidepressants for preventing seasonal affective disorder in adults. Cochrane Database Syst Rev 2015 0.75
98 Implementation of PHQ-9 depression screening for HIV-infected patients in a real-world setting. J Assoc Nurses AIDS Care 2013 0.75
99 When "need plus supply" does not equal demand: challenges in uptake of depression treatment in HIV clinical care. Psychiatr Serv 2014 0.75
100 Recognizing and dealing with depression with psychosis. Essent Psychopharmacol 2005 0.75
101 Comparative effectiveness of dual vs single-action antidepressants on HIV clinical outcomes in HIV-infected people with depression. AIDS 2017 0.75
102 Physician reported communication about depression and psychosocial issues during postpartum visits. N C Med J 2007 0.75
103 Receipt of guideline-concordant pharmacotherapy among children with new diagnoses of bipolar disorder. Psychiatr Serv 2011 0.75
104 Postpartum catatonia treated with electroconvulsive therapy: a case report. Gen Hosp Psychiatry 2012 0.75